Skip to content
← Full study record

NCT03938324 · OUTCOME

Patient Activation as Measured by the Patient Activation Measure (PAM-13)

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions · Source last updated 2026-07-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
score on a scale
Interval / dispersion
Standard Deviation
Time frame
baseline, 3, 6, 9, and 12 months

What was measured

Patient Activation variable measured using the Patient Activation Measure (PAM-13): measures patient activation through self-reports of knowledge, skills, and confidence related to self-management of one's own health care. This 13-item self-report assesses confidence in self-management and understanding of health condition. Each of the 13 items scored on a 5-point Likert scale. The primary outcome is an activation score derived from the 13 items (possible range of 0-100, higher scores indicating higher patient activation in self-management).

Groups in this outcome

PiCASO Intervention Group

Peer coaching intervention delivered by young adults with a childhood onset chronic condition and trained in coaching curriculum that includes motivational interviewing techniques and the benefits of peer relationships over a shared experience such as a chronic condition. The peer coach supports the AYA to identify their goals and feel a sense of success in making change towards goals within a supportive environment. This process involves goal-setting, development of self-discovery and accountability for changes in health behavior. The peer coach elicits the AYA's vision of optimal health and identifies the AYAs values. As the AYAs identify a vision of wellness and develop goals and action steps to progress towards that vision, the peer coach elicits the AYA's intrinsic motivation and activates skill development in self-advocacy and communication and empowers the AYA to take leadership in managing their condition.

Attention Control Group

Over 12 months the attention control group participants will receive a monthly electronic newsletter with educational content about childhood onset chronic condition management and the differences between pediatric and adult health care systems, as well as a monthly phone call from study staff to ensure receipt of the newsletter and to answer questions regarding content, and an opportunity to link them to other resources. If participants report health concerns they will be directed to contact their health care team. Sham Comparator: Attention Control Group: Over 12 months the attention control group participants will receive a monthly electronic newsletter with educational content about childhood onset chronic condition management and the differences between pediatric and adult health care systems, as well as a monthly phone call from study staff to ensure receipt of the newsletter and to answer questions regarding content, and an opportunity to link them to other resources. If participants report health concerns they will be directed to contact their health care team.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
PiCASO Intervention Group147
Attention Control Group75

Reported measurements

Baseline
Values in score on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
PiCASO Intervention Group70.08.4Not reportedNot reportedNot reported
Attention Control Group68.88.7Not reportedNot reportedNot reported
3 months
Values in score on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
PiCASO Intervention Group72.49.2Not reportedNot reportedNot reported
Attention Control Group70.89.6Not reportedNot reportedNot reported
6 months
Values in score on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
PiCASO Intervention Group74.910.0Not reportedNot reportedNot reported
Attention Control Group72.810.4Not reportedNot reportedNot reported
9 months
Values in score on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
PiCASO Intervention Group77.310.9Not reportedNot reportedNot reported
Attention Control Group74.811.3Not reportedNot reportedNot reported
12 months
Values in score on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
PiCASO Intervention Group79.811.7Not reportedNot reportedNot reported
Attention Control Group76.812.1Not reportedNot reportedNot reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. group Description
    Multi-level mixed effects model for longitudinal data to compare treatment group difference in trajectory across 12 months. Group sizes provided at least 80% power to detect a true difference in change trajectories (treatment-by-time interaction effect), assuming a medium effect size, two-tailed tests, and statistical significance set at 0.05. Null hypothesis was no treatment group difference in the trajectory from baseline to 12 months (no significant treatment-by-time effect).
    group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    0.5137
    p Value Comment
    The two-tailed significance set at 0.05 was not adjusted for multiple outcomes or comparisons. No adjustments for pairwise comparisons were required for the model.
    statistical Comment
    Fixed effects were treatment, time, treatment-by time; whereas, random effects were participant and participant-by-time.
    statistical Method
    Multi-level mixed effects
Complete source fields
analyses
  1. group Description
    Multi-level mixed effects model for longitudinal data to compare treatment group difference in trajectory across 12 months. Group sizes provided at least 80% power to detect a true difference in change trajectories (treatment-by-time interaction effect), assuming a medium effect size, two-tailed tests, and statistical significance set at 0.05. Null hypothesis was no treatment group difference in the trajectory from baseline to 12 months (no significant treatment-by-time effect).
    group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    0.5137
    p Value Comment
    The two-tailed significance set at 0.05 was not adjusted for multiple outcomes or comparisons. No adjustments for pairwise comparisons were required for the model.
    statistical Comment
    Fixed effects were treatment, time, treatment-by time; whereas, random effects were participant and participant-by-time.
    statistical Method
    Multi-level mixed effects
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        8.4
        value
        70.0
      2. group Id
        OG001
        spread
        8.7
        value
        68.8
    title
    Baseline
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        9.2
        value
        72.4
      2. group Id
        OG001
        spread
        9.6
        value
        70.8
    title
    3 months
  3. categories
    1. measurements
      1. group Id
        OG000
        spread
        10.0
        value
        74.9
      2. group Id
        OG001
        spread
        10.4
        value
        72.8
    title
    6 months
  4. categories
    1. measurements
      1. group Id
        OG000
        spread
        10.9
        value
        77.3
      2. group Id
        OG001
        spread
        11.3
        value
        74.8
    title
    9 months
  5. categories
    1. measurements
      1. group Id
        OG000
        spread
        11.7
        value
        79.8
      2. group Id
        OG001
        spread
        12.1
        value
        76.8
    title
    12 months
denoms
  1. counts
    1. group Id
      OG000
      value
      147
    2. group Id
      OG001
      value
      75
    units
    Participants
description
Patient Activation variable measured using the Patient Activation Measure (PAM-13): measures patient activation through self-reports of knowledge, skills, and confidence related to self-management of one's own health care. This 13-item self-report assesses confidence in self-management and understanding of health condition. Each of the 13 items scored on a 5-point Likert scale. The primary outcome is an activation score derived from the 13 items (possible range of 0-100, higher scores indicating higher patient activation in self-management).
dispersion Type
Standard Deviation
groups
  1. description
    Peer coaching intervention delivered by young adults with a childhood onset chronic condition and trained in coaching curriculum that includes motivational interviewing techniques and the benefits of peer relationships over a shared experience such as a chronic condition. The peer coach supports the AYA to identify their goals and feel a sense of success in making change towards goals within a supportive environment. This process involves goal-setting, development of self-discovery and accountability for changes in health behavior. The peer coach elicits the AYA's vision of optimal health and identifies the AYAs values. As the AYAs identify a vision of wellness and develop goals and action steps to progress towards that vision, the peer coach elicits the AYA's intrinsic motivation and activates skill development in self-advocacy and communication and empowers the AYA to take leadership in managing their condition.
    id
    OG000
    title
    PiCASO Intervention Group
  2. description
    Over 12 months the attention control group participants will receive a monthly electronic newsletter with educational content about childhood onset chronic condition management and the differences between pediatric and adult health care systems, as well as a monthly phone call from study staff to ensure receipt of the newsletter and to answer questions regarding content, and an opportunity to link them to other resources. If participants report health concerns they will be directed to contact their health care team. Sham Comparator: Attention Control Group: Over 12 months the attention control group participants will receive a monthly electronic newsletter with educational content about childhood onset chronic condition management and the differences between pediatric and adult health care systems, as well as a monthly phone call from study staff to ensure receipt of the newsletter and to answer questions regarding content, and an opportunity to link them to other resources. If participants report health concerns they will be directed to contact their health care team.
    id
    OG001
    title
    Attention Control Group
param Type
MEAN
reporting Status
POSTED
time Frame
baseline, 3, 6, 9, and 12 months
title
Patient Activation as Measured by the Patient Activation Measure (PAM-13)
type
PRIMARY
unit Of Measure
score on a scale

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice